Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
2017
Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study
2006
Painful Hiv-Associated Sensory Neuropathy
2012
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
2009
Immune Reconstitution Syndrome and Exacerbation of Infections after Pregnancy
2007
Weak trophic interactions and the balance of enriched metacommunities
2007
Persistent immune activation in chronic HIV infection
2013
Many scenarios exist for selective inclusion and reporting of results in randomized trials and systematic reviews
2013
Impact of highly active antiretroviral therapy on the spectrum of liver disease in hcv-hiv coinfection
2004
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
The World report on ageing and health: a policy framework for healthy ageing
2015 Standout
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
2013 Standout
Effect ofCYP2B6,ABCB1, andCYP3A5Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study
2010
Hepatitis C Virus in the HIV-Infected Patient
2006
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection
2009
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Inflammatory Co-morbidities in HIV+ Individuals: Learning Lessons from Healthy Ageing
2014
Microglial cell origin and phenotypes in health and disease
2011 Standout
Pharmacology and treatment of neuropathic pains
2009
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons
2004
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
HIV, Antiretroviral Therapies, and the Brain
2010
P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2′,3′-dideoxycytidine
2017
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 Standout
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
2005
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants
2012
The Science of Antibiotic Discovery
2020 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
HIV and Africa's elderly
2012
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
2010 Standout
Human papillomavirus and cervical cancer
2007 Standout
Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial: A5005s, a Substudy of AIDS Clinical Trials Group Study 384
2007
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Management of the metabolic effects of HIV and HIV drugs
2011
A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy
2016 Standout
A plasma microRNA signature of acute lentiviral infection
2011
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study
2014
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians
2015
Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus–Positive Women
2005
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
2010
Voucher reinforcement improves medication adherence in HIV-positive methadone patients: A randomized trial
2006
Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus–Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy
2010
Collagen Deposition Limits Immune Reconstitution in the Gut
2008
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Global change and species interactions in terrestrial ecosystems
2008 Standout
The Hallmarks of Aging
2013 Standout
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26
2007
Current understanding of HIV-associated neurocognitive disorders pathogenesis
2011
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Immunity to fungal infections
2011 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
The pharmacogenetics of antiretroviral therapy
2006
Multidrug efflux pumps: structure, function and regulation
2018 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
2014
Design Issues in Initial HIV-Treatment Trials: Focus on Actg A5095
2006
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
HIV-related neurocognitive impairment – A review
2011
CLIMATE AND FOOD SYNCHRONIZE REGIONAL FOREST BIRD ABUNDANCES
2003
HIV Infection, Inflammation, Immunosenescence, and Aging
2010
Hepatitis C in the HIV-Infected Person
2003
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis
2016
Microneedle Integrated Transdermal Patch for Fast Onset and Sustained Delivery of Lidocaine
2013
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
2008
Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions
2012
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Minocycline: far beyond an antibiotic
2013 Standout
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Depressogenic effects of medications: a review
2011
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
2018
Interventions for enhancing medication adherence
2014 Standout
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source
2017
Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack
2020
Synchronization in complex networks
2008 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Cannabinoids for Medical Use
2015 Standout
Hepatotoxicity of Antiretrovirals
2005
Clinical impact of patient population differences and genomic variation in efavirenz therapy
2008
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Old-Growth Forests Can Accumulate Carbon in Soils
2006 StandoutScience
Oligodendrocytes in HIV-associated pain pathogenesis
2016
The global epidemiology of carbapenemase-producing Enterobacteriaceae
2016 Standout
Industry sponsorship and research outcome
2017 Standout
Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
2008
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study
2012
Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection
2006
Works of Scott Evans being referenced
A Randomized Trial of the Efficacy and Safety of Fenofibrate versus Pravastatin in HIV-Infected Subjects with Lipid Abnormalities: AIDS Clinical Trials Group Study 5087
2005
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial
2017
A Randomized Trial Evaluating Prosaptide™ for HIV-Associated Sensory Neuropathies: Use of an Electronic Diary to Record Neuropathic Pain
2007
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087
2010
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections
2016
Simplification of the Research Diagnosis of HIV-Associated Sensory Neuropathy
2008
Peripheral neuropathy in HIV: prevalence and risk factors
2011
Clinical validation of the NeuroScreen
2005
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance
2014
Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae
2015
Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia
2007
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
2009
Predictive Value of HIV-1 Viral Load on Risk for Opportunistic Infection
2002
Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301
2010
The prevalence and incidence of neurocognitive impairment in the HAART era
2007
When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial
2007
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
2010
Long-Term Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals (ACTG 5097s)
2009
Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects
2002
Experience and Challenges Presented by a Multicenter Crossover Study of Combination Analgesic Therapy for the Treatment of Painful HIV-Associated Polyneuropathies
2013
Antibacterial Resistance Leadership Group: Open for Business
2014
Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy
2004
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
2007
Minocycline treatment for HIV-associated cognitive impairment
2011
HIV neuropathy natural history cohort study
2006
Lower CD4+ T Lymphocyte Nadirs May Indicate Limited Immune Reconstitution in HIV-1 Infected Individuals on Potent Antiretroviral Therapy: Analysis of Immunophenotypic Marker Results of AACTG 5067
2005
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
2020
Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae
2014
MEASURING AND TESTING FOR SPATIAL SYNCHRONY
2001
Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals
2005
The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
2019